{"id":3561,"date":"2026-04-10T08:30:07","date_gmt":"2026-04-10T05:30:07","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/test-listesi\/influenza-antijeni-ab-2\/"},"modified":"2026-04-21T12:39:01","modified_gmt":"2026-04-21T09:39:01","slug":"influenza-antijeni-ab","status":"publish","type":"page","link":"https:\/\/merkezlaboratuvari.com\/ar\/test-listesi\/influenza-antijeni-ab\/","title":{"rendered":"Influenza Antijeni (A+B)"},"content":{"rendered":"<h1>Influenza Antijeni (A+B)<\/h1>\n<h2>Laboratuvar Bilgileri<\/h2>\n<ul>\n<li><strong>Yeni Kod:<\/strong> MIK5856<\/li>\n<li><strong>SUT Kodu:<\/strong> 907660.0<\/li>\n<li><strong>Eski Kod:<\/strong> \u0130S0132<\/li>\n<li><strong>Kategori:<\/strong> \u0627\u0644\u0623\u062d\u064a\u0627\u0621 \u0627\u0644\u062f\u0642\u064a\u0642\u0629<\/li>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Nazal Ak\u0131nt\u0131<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Jelsiz Swab<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ertesi g\u00fcn 18:00<\/li>\n<\/ul>\n<h2>Influenza Antijeni (A+B) Testi Nedir?<\/h2>\n<p>Influenza Antijeni (A+B), laboratuvar ortam\u0131nda de\u011ferlendirilen bir mikrobiyoloji testidir. De\u011ferlendirme \u00e7o\u011fu zaman nazal ak\u0131nt\u0131 \u00f6rne\u011fi \u00fczerinden planlan\u0131r.<\/p>\n<p>\u0130nfluenza antijen testi, \u0130nfluenza A ve \u0130nfluenza B vir\u00fcslerinin antijenlerini solunum yolu \u00f6rneklerinden h\u0131zl\u0131 \u015fekilde tespit eden bir tan\u0131 testidir. Grip (influenza) tan\u0131s\u0131nda ve tip ayr\u0131m\u0131nda kullan\u0131l\u0131r. Sonu\u00e7 dakikalar i\u00e7inde al\u0131nd\u0131\u011f\u0131ndan tedavi karar\u0131n\u0131 h\u0131zland\u0131r\u0131r.<\/p>\n<p>Bu testin klinik anlam\u0131; istem nedeni, hastan\u0131n yak\u0131nmalar\u0131, ya\u015f\u0131, e\u015flik eden hastal\u0131klar\u0131, kullan\u0131lan y\u00f6ntem ve di\u011fer laboratuvar bulgular\u0131 ile birlikte de\u011ferlendirilir. Bu nedenle sonu\u00e7, tek ba\u015f\u0131na de\u011fil, b\u00fct\u00fcnc\u00fcl t\u0131bbi \u00e7er\u00e7eve i\u00e7inde yorumlanmal\u0131d\u0131r.<\/p>\n<h2>Influenza Antijeni (A+B) Hangi Durumlarda \u0130stenir?<\/h2>\n<p>Influenza Antijeni (A+B) testi, hekim taraf\u0131ndan klinik gereklilik g\u00f6r\u00fclen durumlarda istenebilir. \u0130stem gerek\u00e7esi hastan\u0131n mevcut tablosuna g\u00f6re de\u011fi\u015febilir.<\/p>\n<ul>\n<li>Grip benzeri semptomlarla ba\u015fvuran hastalarda (ani ate\u015f, miyalji, \u00f6ks\u00fcr\u00fck, bo\u011faz a\u011fr\u0131s\u0131)<\/li>\n<li>Antiviral tedavi (oseltamivir) karar\u0131 vermede<\/li>\n<li>Grip salg\u0131nlar\u0131nda h\u0131zl\u0131 tarama<\/li>\n<li>Hastane enfeksiyon kontrol\u00fcnde izolasyon karar\u0131<\/li>\n<li>\u0130nfluenza A ve B tip ayr\u0131m\u0131nda<\/li>\n<\/ul>\n<p>Ayn\u0131 test farkl\u0131 hastalarda farkl\u0131 klinik sorulara yan\u0131t aramak amac\u0131yla kullan\u0131labildi\u011fi i\u00e7in, nihai de\u011ferlendirme her zaman ki\u015fisel t\u0131bbi \u00f6yk\u00fc ve muayene bulgular\u0131 ile birlikte yap\u0131lmal\u0131d\u0131r.<\/p>\n<h2>Influenza Antijeni (A+B) Testi \u00d6ncesi Haz\u0131rl\u0131k<\/h2>\n<p>Haz\u0131rl\u0131k gereksinimi; testin t\u00fcr\u00fcne, numune yap\u0131s\u0131na ve laboratuvar\u0131n \u00e7al\u0131\u015fma kurallar\u0131na g\u00f6re de\u011fi\u015febilir. Test \u00f6ncesinde laboratuvar\u0131n ve hekimin verdi\u011fi talimatlar esas al\u0131nmal\u0131d\u0131r.<\/p>\n<ul>\n<li>\u00d6zel bir haz\u0131rl\u0131k gerekmez.<\/li>\n<li>Semptomlar\u0131n ilk 48 saatinde al\u0131nan \u00f6rnekler daha g\u00fcvenilir sonu\u00e7 verir.<\/li>\n<\/ul>\n<p>Kullan\u0131lan ila\u00e7lar, takviyeler, yak\u0131n d\u00f6nemde ge\u00e7irilen hastal\u0131klar ve e\u015flik eden kronik durumlar sonucun yorumlanmas\u0131n\u0131 etkileyebilece\u011fi i\u00e7in sa\u011fl\u0131k profesyoneli ile payla\u015f\u0131lmal\u0131d\u0131r.<\/p>\n<h2>Influenza Antijeni (A+B) Testi Nas\u0131l Yap\u0131l\u0131r?<\/h2>\n<p>Influenza Antijeni (A+B) testi, uygun biyolojik \u00f6rnek al\u0131nd\u0131ktan sonra laboratuvar\u0131n belirledi\u011fi y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r. Numunenin do\u011fru zamanda, uygun kapta ve uygun ta\u015f\u0131ma ko\u015fullar\u0131nda ula\u015ft\u0131r\u0131lmas\u0131 test kalitesi a\u00e7\u0131s\u0131ndan \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Nazal Ak\u0131nt\u0131<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Jelsiz Swab<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ertesi g\u00fcn 18:00<\/li>\n<\/ul>\n<ul>\n<li>Nazofaringeal s\u00fcr\u00fcnt\u00fc veya nasal y\u0131kama\/aspirat \u00f6rne\u011fi al\u0131n\u0131r.<\/li>\n<li>\u0130mm\u00fcnokromatografik h\u0131zl\u0131 test ile \u00e7al\u0131\u015f\u0131l\u0131r.<\/li>\n<li>H\u0131zl\u0131 test sonucu 10\u201320 dakika i\u00e7inde okunabilir; resmi raporlama ertesi g\u00fcn 18:00 itibar\u0131yla yap\u0131l\u0131r.<\/li>\n<\/ul>\n<p>Baz\u0131 durumlarda \u00f6rnek kalitesi, numune miktar\u0131, ta\u015f\u0131ma s\u00fcresi veya teknik tekrar gereksinimi raporlama s\u00fcresini ve sonucun g\u00fcvenilirli\u011fini etkileyebilir.<\/p>\n<h2>Influenza Antijeni (A+B) Testi Ka\u00e7 G\u00fcnde \u00c7\u0131kar?<\/h2>\n<p>Mevcut laboratuvar bilgisine g\u00f6re bu test i\u00e7in raporlama s\u00fcresi: <strong>Ertesi g\u00fcn 18:00<\/strong> \u015feklindedir.<\/p>\n<p>Numunenin kabul zaman\u0131, laboratuvar\u0131n \u00e7al\u0131\u015fma plan\u0131, resmi tatiller veya gerekti\u011finde tekrar \u00e7al\u0131\u015fma gibi etkenler sonucu etkileyebilece\u011fi i\u00e7in en g\u00fcncel bilgi rapor tarihi \u00fczerinden de\u011ferlendirilmelidir.<\/p>\n<h2>Referans De\u011ferleri ve Sonu\u00e7lar\u0131n De\u011ferlendirilmesi<\/h2>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>\u0627\u0644\u0646\u062a\u064a\u062c\u0629<\/th><th>Yorum<\/th><\/tr><\/thead><tbody><tr><td>\u0130nfluenza A Negatif \/ B Negatif<\/td><td>Her iki tip de saptanmad\u0131<\/td><\/tr><tr><td>\u0130nfluenza A Pozitif<\/td><td>\u0130nfluenza A enfeksiyonu<\/td><\/tr><tr><td>\u0130nfluenza B Pozitif<\/td><td>\u0130nfluenza B enfeksiyonu<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>Referans bilgileri; kullan\u0131lan y\u00f6ntem, ya\u015f grubu, biyolojik \u00f6rnek tipi ve laboratuvar standard\u0131na g\u00f6re de\u011fi\u015febilece\u011finden, rapor \u00fczerinde yer alan laboratuvar yorumu esas al\u0131nmal\u0131d\u0131r.<\/p>\n<h2>Influenza Antijeni (A+B) Sonucu Nas\u0131l Yorumlan\u0131r?<\/h2>\n<p>Test sonucu tek ba\u015f\u0131na kesin tan\u0131 koydurmaz. Sonu\u00e7; klinik bulgular, di\u011fer laboratuvar verileri ve gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek incelemeler ile birlikte de\u011ferlendirilir.<\/p>\n<ul>\n<li><strong>Pozitif sonu\u00e7<\/strong>: \u0130lgili \u0130nfluenza tipinin enfeksiyonunu g\u00f6sterir. Semptomlar\u0131n ilk 48 saatinde antiviral tedavi (oseltamivir) ba\u015flanabilir.<\/li>\n<li><strong>Negatif sonu\u00e7<\/strong>: \u0130nfluenza enfeksiyonunu kesin olarak d\u0131\u015flamaz. H\u0131zl\u0131 testlerin duyarl\u0131l\u0131\u011f\u0131 %50\u201370 aras\u0131ndad\u0131r. Klinik \u015f\u00fcphe devam ederse PCR (RT-PCR) ile do\u011frulama yap\u0131lmal\u0131d\u0131r.<\/li>\n<li>\u0130nfluenza RT-PCR, h\u0131zl\u0131 antijen testlerinden \u00e7ok daha duyarl\u0131d\u0131r ve alt\u0131n standart tan\u0131 y\u00f6ntemidir.<\/li>\n<li>Testin duyarl\u0131l\u0131\u011f\u0131 semptom s\u00fcresine, \u00f6rnek kalitesine ve viral y\u00fcke ba\u011fl\u0131d\u0131r; semptomlar\u0131n ilk 24\u201348 saatinde en y\u00fcksek duyarl\u0131l\u0131\u011fa sahiptir.<\/li>\n<\/ul>\n<p>\u00d6zellikle s\u0131n\u0131rda, d\u00fc\u015f\u00fck d\u00fczeyli veya beklenmeyen sonu\u00e7larda klinik korelasyon gerekir. Gerekti\u011finde tekrar test, panel de\u011ferlendirmesi veya ek laboratuvar incelemeleri planlanabilir.<\/p>\n<h2>Testin S\u0131n\u0131rl\u0131l\u0131klar\u0131<\/h2>\n<p>Her laboratuvar testinde oldu\u011fu gibi bu incelemenin de baz\u0131 s\u0131n\u0131rl\u0131l\u0131klar\u0131 vard\u0131r. Sonu\u00e7; \u00f6rnek kalitesi, \u00f6rnekleme zaman\u0131, ta\u015f\u0131ma ko\u015fullar\u0131 ve klinik ba\u011flamdan etkilenebilir.<\/p>\n<ul>\n<li>Tek bir laboratuvar sonucu, klinik \u00e7er\u00e7eve d\u0131\u015f\u0131nda eksik yorumlanabilir.<\/li>\n<li>Uygun olmayan numune kalitesi sonucun g\u00fcvenilirli\u011fini azaltabilir.<\/li>\n<li>Gerekti\u011finde ek testler olmadan tek ba\u015f\u0131na karar vermek yan\u0131lt\u0131c\u0131 olabilir.<\/li>\n<\/ul>\n<h2>Olas\u0131 Riskler<\/h2>\n<p>Risk \u00e7o\u011funlukla numune alma ve numune y\u00f6netimi s\u00fcreci ile ili\u015fkilidir. Testin kendisinden \u00e7ok, \u00f6rne\u011fin al\u0131nmas\u0131 ve uygun ko\u015fullarda \u00e7al\u0131\u015f\u0131lmas\u0131 \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li>Nazofaringeal s\u00fcr\u00fcnt\u00fc al\u0131m\u0131nda k\u0131sa s\u00fcreli rahats\u0131zl\u0131k, hap\u015f\u0131rma veya g\u00f6zlerin sulanmas\u0131 olabilir.<\/li>\n<li>Testin kendisine \u00f6zg\u00fc ciddi bir risk bulunmaz.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Influenza Antijeni (A+B) Laboratuvar Bilgileri Yeni Kod: MIK5856 SUT Kodu: 907660.0 Eski Kod: \u0130S0132 Kategori: Mikrobiyoloji Numune T\u00fcr\u00fc: Nazal Ak\u0131nt\u0131 Numune Kab\u0131: Jelsiz Swab \u00c7al\u0131\u015fma G\u00fcn\u00fc: Her g\u00fcn \u00d6nemli Kriter: \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r. Raporlama Tarihi: Ertesi g\u00fcn 18:00 Influenza Antijeni (A+B) Testi Nedir? Influenza Antijeni (A+B), [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":5,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"test_category":"Mikrobiyoloji","test_kodu":"MIK5856","numune_turu":"Nazal Ak\u0131nt\u0131","numune_kabi":"Jelsiz Swab","calisma_gunu":"Her g\u00fcn","onemli_kriter":"\u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.","raporlama_tarihi":"Ertesi g\u00fcn 18:00","numune_red_kriterleri":"","aktarim_kodu":"","loinc_kodu":"","sut_kodu":"907660","akredite":"","numune_miktari":"","alternatif_ornek":"","numune_alinma_sekli":"","stabilite_ozellikleri":"","calisma_yontemi":"","test_bilgisi":"","footnotes":""},"class_list":["post-3561","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=3561"}],"version-history":[{"count":4,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3561\/revisions"}],"predecessor-version":[{"id":9119,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3561\/revisions\/9119"}],"up":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/5"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=3561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}